Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Video Roundtable: APAC Team Talks Key Regional Trends And Topics

Executive Summary

Join Scrip's APAC content team for a video overview of major trends and topics in the regional biopharma industry over the past few months.

From China's new pharma anti-corruption drive to Indian generic firms' strategics challenges, Korean biotechs' global ambitions and Japanese companies' performance in the fiscal first quarter, the APAC region presents a highly varied set of operating environments, challenges and opportunities.

Join Scrip's on-the-ground team - Brian Yang, Dexter Yan, Anju Ghangurde, Vibha Ravi, Jung Won Shin, Lisa Takagi and myself - in this video overview of recent major biopharma industry topics and trends. 

Selected stories covering themes discussed in the roundtable:

(Also see "China’s New Pharma Corruption Push Set For At Least A Year" - Scrip, 18 Aug, 2023.)

(Also see "China Drug Makers Brace As Anti-Graft Campaign Impact Surfaces" - Scrip, 24 Aug, 2023.)

(Also see "Sun Pharma Chief: We Are Not 'All In' In Biologics" - Scrip, 16 Aug, 2023.)

(Also see "Draft Biosimilar Red Tape Elimination Act: Pharmacist As Ally, Would Patients Benefit?" - Scrip, 25 Aug, 2023.)

(Also see "Korea Q2 Roundup: New Drugs Drive Growth, First-Line Lazertinib Approval" - Scrip, 1 Aug, 2023.)

(Also see "Japan Q1 Roundup: High Hopes For Leqembi And Veozah, Forex Give And Take" - Scrip, 3 Aug, 2023.)

For more company information, visit and

Video timestamps:


02:00 China pharma corruption drive

08:20 China company earnings

13:20 India company earnings/outlook

17:25 India impact of US Biosimilar Red Tape Elimination Act

22:10 Korean firms eye global market; Korean govt industry support 

22:46 Japanese firms' earnings; Japan policy trends 

29:45 Summary/outro 

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts